Download the Ultimate Clinical Trial Tracking Checklist
Tuesday, April 14, 2020 | 11:00 AM – 12:00 PM EDT |
Part 1: Clinical Trials and COVID-19: Situation Now, its challenges, and the Future
The novel COVID-19 virus has forced a lot of rapid changes in a very short period. Personally and professionally, we are all learning how to adapt. While restrictions on our day-to-day lives impact where, why, and how we interact, we still can come together as a community to learn, grow, and overcome.
TransPerfect Life Sciences hosted Part 1 of the Clinical Trials and COVID-19 webinar series with industry experts to exchange ideas and provide insights into the impact of COVID-19 on clinical trials.
Michael Smyth
Division President
Craig Lipset
Managing Partner, Clinical Innovation Partners
Michael Katz
Vice President, Development Operations | Farring Pharmaceuticals
Francesca Carvajal
Associate Vice President Regional Head Global Clinical Trial Operations for LatinAmerica at MSD